AU2008262438A1 - Compositions useful for treating gastroesophageal reflux disease - Google Patents

Compositions useful for treating gastroesophageal reflux disease Download PDF

Info

Publication number
AU2008262438A1
AU2008262438A1 AU2008262438A AU2008262438A AU2008262438A1 AU 2008262438 A1 AU2008262438 A1 AU 2008262438A1 AU 2008262438 A AU2008262438 A AU 2008262438A AU 2008262438 A AU2008262438 A AU 2008262438A AU 2008262438 A1 AU2008262438 A1 AU 2008262438A1
Authority
AU
Australia
Prior art keywords
subject
proton pump
compound
dose
pump inhibitor
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2008262438A
Other languages
English (en)
Inventor
Steven B. Landau
Suhail Nurbhai
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Dynogen Pharmaceuticals Inc
Original Assignee
Dynogen Pharmaceuticals Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Dynogen Pharmaceuticals Inc filed Critical Dynogen Pharmaceuticals Inc
Publication of AU2008262438A1 publication Critical patent/AU2008262438A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/439—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom the ring forming part of a bridged ring system, e.g. quinuclidine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Plural Heterocyclic Compounds (AREA)
AU2008262438A 2007-06-07 2008-06-04 Compositions useful for treating gastroesophageal reflux disease Abandoned AU2008262438A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US93353507P 2007-06-07 2007-06-07
US60/933,535 2007-06-07
PCT/US2008/007038 WO2008153884A1 (en) 2007-06-07 2008-06-04 Compositions useful for treating gastroesophageal reflux disease

Publications (1)

Publication Number Publication Date
AU2008262438A1 true AU2008262438A1 (en) 2008-12-18

Family

ID=39619385

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2008262438A Abandoned AU2008262438A1 (en) 2007-06-07 2008-06-04 Compositions useful for treating gastroesophageal reflux disease

Country Status (8)

Country Link
US (3) US20090131471A1 (https=)
EP (1) EP2152263A1 (https=)
JP (1) JP2010529125A (https=)
CN (1) CN101868236A (https=)
AU (1) AU2008262438A1 (https=)
CA (1) CA2690581A1 (https=)
RU (1) RU2009149637A (https=)
WO (1) WO2008153884A1 (https=)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP5692838B2 (ja) * 2009-12-15 2015-04-01 公立大学法人横浜市立大学 感覚器障害モデル動物
US20120225922A1 (en) * 2011-03-04 2012-09-06 Qr Pharma Effective Amounts of (3aR)-1,3a,8-Trimethyl-1,2,3,3a,8,8a-hexahydropyrrolo [2,3-b]indol-5-yl Phenylcarbamate and Methods of Treating or Preventing Neurodegeneration
US20150164047A1 (en) * 2013-11-07 2015-06-18 Urban Pet Haus, LLC Edible cat toy

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2699794B2 (ja) * 1992-03-12 1998-01-19 三菱化学株式会社 チエノ〔３，２−ｂ〕ピリジン誘導体
US6132768A (en) * 1995-07-05 2000-10-17 Byk Gulden Lomberg Chemische Fabrik Gmbh Oral pharmaceutical composition with delayed release of active ingredient for reversible proton pump inhibitors
JP3927738B2 (ja) * 1999-10-25 2007-06-13 キヤノン株式会社 通信システム
TWI256314B (en) * 2000-02-09 2006-06-11 Mitsubishi Pharma Corp Preventive-therapeutical medicament for gastroesophageal reflux disease
UA80393C2 (uk) * 2000-12-07 2007-09-25 Алтана Фарма Аг Фармацевтична композиція, яка містить інгібітор фде 4, диспергований в матриці
BRPI0414046A (pt) * 2003-08-29 2006-10-24 Dynogen Pharmaceuticals Inc método de tratamento de um distúrbio de motilidade gastrintestinal, de tratamento de "gerd", de "gerd" noturno, composição farmacêutica, kit que compreende um composto e método para aumentar a motilidade esofágica em um paciente

Also Published As

Publication number Publication date
WO2008153884A8 (en) 2009-03-26
CA2690581A1 (en) 2008-12-18
US20100247584A1 (en) 2010-09-30
WO2008153884A1 (en) 2008-12-18
EP2152263A1 (en) 2010-02-17
RU2009149637A (ru) 2011-07-20
CN101868236A (zh) 2010-10-20
JP2010529125A (ja) 2010-08-26
US20110275667A1 (en) 2011-11-10
US20090131471A1 (en) 2009-05-21

Similar Documents

Publication Publication Date Title
US8039456B2 (en) Method of stimulating the motility of the gastrointestinal system using ipamorelin
JP2003523324A (ja) 組合せ医薬および胃腸疾患の処置へのそれらの使用
AU2009236019B9 (en) Compositions useful for treating gastrointestinal motility disorders
US20120164139A1 (en) Dopamine 3 receptor agonist and antagonist treatment of gastrointestinal motility disorders
US20110275667A1 (en) Compositions useful for treating gastroesophageal reflux disease
EP2203055A1 (en) 1-methyl nicotinamide and derivatives for treatment of gastric injury
JP2013040206A (ja) 消化器系の運動をイパモレリンを用いて刺激する方法
US9889125B2 (en) Methods for treating heartburn, gastric bleeding or hemorrhage in patients receiving clopidogrel therapy
KR20250026332A (ko) 과민성 방광 증후군의 치료 또는 예방 방법
JP2023052054A (ja) トリアザスピロ［４．５］デカノンによる胃不全麻痺の処置
ZA200602317B (en) Composition useful for treating gastrointestinal motility disorders
TW201924677A (zh) 苯并咪唑衍生物用於夜間酸突破的用途
WO2008100422A1 (en) Compositions comprising mkc-733 (pumosetrag) useful for treating irritable bowel syndrome

Legal Events

Date Code Title Description
MK1 Application lapsed section 142(2)(a) - no request for examination in relevant period